Latest News

Piper

TILT Biotherapeutics was highlighted as one of the key companies developing oncolytic viruses in an interesting report entiteled ” A New Wave of Cancer Therapies: Local Tumor Immuno-Rx Drives Distant Effects”, published by Piper Jaffray & Co.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

June 13-16th 2022
San Diego (CA), U.S.A.
28-29th September 2022
Malmö, Sweden
28th September - 1st of October 2022
New York City (NY), U.S.A.
24-26th October 2022
Leipzig, Germany